SCHEMBL1280773

SCHEMBL1280773

O=C(O)Cn1ccccc1=O

nearest known ligand 0.56

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.56
ALDH1A1 P00352 2/20 0.53
MAPT P10636 2/20 0.53
KMT2A Q03164 2/20 0.53
MEN1 O00255 1/20 0.53
LMNA P02545 1/20 0.53
ALOX12 P18054 1/20 0.53
RECQL P46063 1/20 0.53
POLB P06746 2/20 0.52
KDM4E B2RXH2 1/20 0.52
PSMB5 P28074 2/20 0.49
PSMB1 P20618 2/20 0.49
APEX1 P27695 1/20 0.47
CA12 O43570 1/20 0.47
CA9 Q16790 1/20 0.47
PREP P48147 1/20 0.47
FAP Q12884 1/20 0.47
PTGS2 P35354 1/20 0.46
NPSR1 Q6W5P4 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9752669 0.85 TSHR (0.57) TSHRALDH1A1MAPTKMT2AMEN1
SCHEMBL10656937 0.82 TSHR (0.59) TSHRALDH1A1MAPTKMT2AMEN1
SCHEMBL11964126 0.82 TSHR (0.54) TSHRALDH1A1MAPTLMNAPOLB
SCHEMBL10842925 0.82 TSHR (0.50) TSHRALDH1A1MAPTKMT2AMEN1
SCHEMBL11827268 0.82 TSHR (0.54) TSHRALDH1A1MAPTKMT2AMEN1
SCHEMBL4956341 0.82 TSHR (0.54) TSHRKMT2ALMNAPOLBPSMB5
SCHEMBL21855432 0.80 PSMB1 (0.62) TSHRMAPTKMT2AMEN1LMNA
SCHEMBL9752613 0.79 TSHR (0.51) TSHRALDH1A1MAPTKMT2AMEN1
SCHEMBL12530443 0.79 TSHR (0.51) TSHRALDH1A1MAPTLMNAPOLB
SCHEMBL10815571 0.78 KMT2A (0.51) TSHRALDH1A1MAPTKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 63 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2026107328-A1 AGONISTS OF PARATHYROID HORMONE 1 AND INCRETIN RECEPTORS SEPTERNA, INC. (US) 2026-05-21 WO disclosed
US-20250339569-A1 CARBONIC ANHYDRASE IX LIGANDS 3B PHARMACEUTICALS GMBH (DE) 2025-11-06 US disclosed
WO-2025072539-A1 AMINO ACID COMPOUNDS WITH NITROGEN LINKERS AND USES THEREOF PLIANT THERAPEUTICS, INC. (US) 2025-04-03 WO disclosed
US-20230357347-A1 MODULATORS OF G-PROTEIN COUPLED RECEPTORS CARMOT THERAPEUTICS, INC. 2023-11-09 US disclosed
US-20230357347-A1 MODULATORS OF G-PROTEIN COUPLED RECEPTORS CARMOT THERAPEUTICS, INC. 2023-11-09 US disclosed
WO-2023192578-A1 PROTEIN DEGRADERS AND USES THEREOF KYMERA THERAPEUTICS, INC. (US) 2023-10-05 WO disclosed
CN-111662228-B Pyridone acyl biarylamine compounds and uses thereof 中国医学科学院药物研究所 2023-07-28 CN disclosed
WO-2023111350-A2 CARBONIC ANHYDRASE IX LIGANDS 3B PHARMACEUTICALS GMBH (DE) 2023-06-22 WO disclosed
US-11535597-B2 Photoreactive ligands and uses thereof THE SCRIPPS RESEARCH INSTITUTE (US) 2022-12-27 US disclosed
US-11535597-B2 Photoreactive ligands and uses thereof THE SCRIPPS RESEARCH INSTITUTE (US) 2022-12-27 US disclosed
US-4096256-A ANTIBIOTICS SMITHKLINE CORPORATION (US) 1978-06-20 US disclosed
US-4068073-A BACTERICIDES SMITHKLINE CORPORATION (US) 1978-01-10 US disclosed
US-4067880-A SULFOALKYL-OXADIAZOLE THIOLS SMITHKLINE CORPORATION (US) 1978-01-10 US disclosed
US-4066761-A ANTIBACTERIAL SMITHKLINE CORPORATION (US) 1978-01-03 US disclosed
US-4059591-A Ureidoalkyl substituted tetrazole thiol intermediates for preparing cephalosporins SMITHKLINE CORPORATION (US) 1977-11-22 US disclosed
US-4041162-A ANTIBIOTICS, BACTERICIDES SMITHKLINE CORPORATION (US) 1977-08-09 US disclosed
US-4034092-A ANTIBACTERIAL SMITHKLINE CORPORATION (US) 1977-07-05 US disclosed
US-4025626-A ANTIBACTERIAL SMITHKLINE CORPORATION (US) 1977-05-24 US disclosed
US-3994874-A ANTIBACTERIAL RICHARDSON-MERRELL INC. (US) 1976-11-30 US disclosed
US-3956287-A BACTERICIDES RICHARDSON-MERRELL INC. (US) 1976-05-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230357347-A1 MODULATORS OF G-PROTEIN COUPLED RECEPTORS GIPR, GLP1R, GCGR TSHR 140/4885ALDH1A1 3305/4885MAPT 3149/4885
US-11535597-B2 Photoreactive ligands and uses thereof CLTB, CRYAB, CRYAA TSHR 2715/4885ALDH1A1 2216/4885MAPT 3004/4885
US-20250339569-A1 CARBONIC ANHYDRASE IX LIGANDS CA9, CA13, CA4 TSHR 870/4885ALDH1A1 4281/4885MAPT 2838/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.